2017 Georgia New Pharmacy/Medical Legislative Activity. Revised,

Transcription

1 2017 Georgia New Pharmacy/Medical Legislative Activity Revised, This document provides a summary of key points regarding each individual piece of legislation. Readers are to full current versions in order to develop their own comprehensive understanding of each piece of legislation and its potential implications. Bill Sponsor Status Summary HB 30 Tanner, K 9 th district A BILL to be entitled an Act to amend Code Section of the Official Code of Georgia Annotated, relating to Schedule I controlled substances, so as add a synthetic opioid to Schedule I; to provide for related matters US/Display/ /HB/30 HB 35 Broadrick, Bruce 4th managers, so as to require confirmation of receipt of prior approval requests for prescription drugs within 48 hours; to provide for applicability; to provide for related matters US/Display/ /HB/35 HB 36 Erhart, E 36th relating to optometrists, so as to change and provide certain definitions to permit doctors of optometry to administer pharmaceutical agents by injection under certain circumstances; to provide for related matters; US/Display/ /HB/36 SB 16 Watson, B 1st Senate relating to the regulation of low THC oil and the establishment of the Low THC Oil Patient Registry, definitions, purpose, registration cards, quarterly reports, and waiver forms, respectively, so as to change the definition of low THC oil; to change provisions relating to conditions eligible for use of low THC oil US/Display/ /SB/16 HB 55 HB 65 Williams, R 145th Peak, A 141 st relating to general provisions relative to professions and businesses, so as to limit the number of consecutive years an individual may serve as a member of a professional licensing board; to provide for related matters US/Display/ /HB/55 relating to the establishment of the Low THC Oil Patient Registry, definitions, purpose, registration cards, quarterly

2 HR 36 Stephens, Ron 164 Peake, A 141st reports, and waiver forms, so as to change provisions relating to conditions and eligibility; to provide a definition; to remove certain reporting requirements; to provide for related matters: US/Display/ /HB/65 Adds conditions covered under the THC Oil Patient Registry to include Tourette s, autism, PTSD, Alzheimer s, HIV/Aids and intractable pain. A RESOLUTION proposing an amendment to the Constitution so as to authorize the General Assembly to provide by law for the regulation of the production of cannabis and sale of medical cannabis to certain individuals for medical usage as provided by law; to provide that the fees paid from the production of cannabis and state tax proceeds from the sale of medical cannabis be dedicated; to provide that such funds shall not lapse; to provide for submission of this amendment for ratification or rejection; US/Display/ /HR/36 SB 41 Unterman, R. 45th Senate relating to pharmacists and pharmacies, so as to provide for the licensure of durable medical equipment suppliers; to provide for a definition; to provide for requirements for licensure; to provide for discipline and revocation; to provide for inspections; to provide for exemptions; to provide for rules and regulations; to provide for related matters US/Display/ /SB/41 SB 88 Mullis, J 53rd 1/30, Senate relating to drug abuse treatment and education programs, so as to provide for regulation of narcotic treatment programs; US/Display/ /SB/88 SB 81 Unterman, R. 45th 1/30, Senate 2/10, Senate committee favorably report by substitute Part I known as: Jeffrey Dallas Gay Jr. Act Part II known as: Substance abuse treatment and overdose prevention act (STOP Act) relating to pharmacies, so as to provide that the state health officer may issue a standing order permitting certain persons and entities to obtain opioid antagonists under the conditions the state health officer may impose; to amend Chapter 13 of Title 16 of the O.C.G.A., relating to controlled substances; to amend Code Section of the O.C.G.A., relating to reporting disease, confidentiality, reporting required by pharmacists, immunity from liability

3 HB 231 Broadrick, Bruce 4th 2/2, House first as to information supplied, and notification of potential bioterrorism; to amend Chapter 5 of Title 26 of the O.C.G.A., relating to drug abuse treatment and education programs US/Display/ /SB/81 Line 259: A prescriber shall seek and review information from the electronic database whenever he or she is prescribing a CII, II, IV, or V controlled substance to a patient for the first time (see exemptions) Line 276: Prescriber shall not issue a prescription for more than a five day supply Line 305: A prescriber who knowingly and intentionally fails to seek and review shall be guilty of a felony relating to controlled substances, so as to change certain provisions relating to Schedules I, II, IV, and V controlled substances; to change certain provisions relating to the definition of dangerous drug; to provide for related matters; to provide for an effective date US/Display/ /HB/231 HB 249 Tanner, K 9th 2/2, House hopper relating to controlled substances and death investigations, respectively, so as to collect more information regarding the dispensing and use of certain controlled substances; to change the frequency of reporting certain prescriptions in the electronic data base of prescription information; to clarify provisions relating to confidentiality; to change provisions relating to liability and duties; to change provisions relating to the definitions of dangerous drugs; to provide for a coroner's inquest when an individual dies of a suspected drug overdose US/Display/ /HB/249 SB 103 Mullis, J 53rd 2/1, Senate managers, so as to authorize the Commissioner of Insurance to promulgate certain rules and regulations and to examine and investigate certain matters with regard to pharmacy benefits managers; to prohibit pharmacy benefits managers from requiring the use of mail order pharmacies under certain conditions; to provide for exceptions; to provide for certain prohibitions; to provide for enforcement; to provide a short title; to provide for related matters US/Display/ /SB/103

4 HB 276 SB 106 Knight, David 130th Kirk, G 13th 2/9, 2/1, Senate managers, so as to authorize the Commissioner of Insurance to promulgate certain rules and regulations and to examine and investigate certain matters with regard to pharmacy benefits managers; to prohibit pharmacy benefits managers from requiring the use of mail order pharmacies under certain conditions; US/Display/ /HB/276 Pharmacy Patient Fair Practices Act (Companion bill for SB 103) relating to licensure requirements for pain management clinics, so as to revise a provision relating to the health care professionals who must be on site at a pain management clinic in order for the clinic to provide medical treatment or services US/Display/ /SB/106 SB 121 Miller 49th relating to pharmacies, so as to provide that the state health officer may issue a standing order permitting certain persons and entities to obtain opioid antagonists under the conditions the state health officer may impose; to provide for immunity; to amend Chapter 13 of Title 16 of the Official Code of Georgia Annotated, relating to controlled substances, so as to change the definition of a dangerous drug; to add a drug to Schedule V US/Display/ /SB/121 SB 123 Hill, Hunter 2/8, Senate relating to state health planning and development, so as to eliminate the 65 percent out of state patient base requirement for a destination cancer hospital for purposes of certificate of need; to eliminate the 50 bed limitation on destination cancer hospitals; to provide that destination cancer hospitals can increase bed capacity under certain conditions; to eliminate the limitation on the number of destination cancer hospitals that can be issued a certificate of need US/Display/ /SB/123 SB 125 Jeffares, R 17th 2/8, Senate relating to delegation of authority to physician assistants, so as to authorize a physician to delegate to a physician assistant the authority to prescribe hydrocodone compound products; to provide for a limitation; to provide

5 for additional continuing education requirements regarding hydrocodone compound products US/Display/ /SB/125